PARADIGM CAPITAL MANAGEMENT INC/NY Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$2.1B

Holdings

122

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (122 positions)

#	Stock	Shares	Value	% Portfolio
101	HALOHalozyme Therapeutics, Inc.	10,000	$520K	0.03%
102	ICHRIchor Holdings	26,000	$511K	0.02%
103	HIHillenbrand Inc	23,300	$468K	0.02%
104	QA4AGentherm Inc	15,000	$424K	0.02%
105	PGProcter & Gamble	2,500	$398K	0.02%
106	PRIMPrimoris Services Corp	5,000	$390K	0.02%
107	TELATELA Bio, Inc.	200,000	$388K	0.02%
108	FW2NBanner Corp New	6,000	$385K	0.02%
109	AMATApplied Materials	2,000	$366K	0.02%
110	EWEdwards Lifesciences Corporation	4,400	$344K	0.02%
111	NBHCNational Bank Hldgs Corp Cl A	9,000	$338K	0.02%
112	FNFFidelity National Financial	5,900	$331K	0.02%
113	PFEPfizer, Inc	11,400	$276K	0.01%
114	NVMINova Measuring Instruments Ltd	1,000	$275K	0.01%
115	JXC1Ziff-Davis Inc	8,350	$253K	0.01%
116	NEOGNeogen Corporation	52,000	$249K	0.01%
117	HROWHarrow Inc.	8,000	$244K	0.01%
118	BMYBristol-Myers Squibb	5,100	$236K	0.01%
119	CMBMCambium Networks Corporation	466,900	$189K	0.01%
120	LAKELakeland Industies, Inc.	10,000	$136K	0.01%
121	CDXSCodexis, Inc.	50,000	$122K	0.01%
122	FLBStandard BioTools Inc.	17,457	$21K	0.00%

PreviousPage 2 of 2